Producer cell line for NHSBT's viral vector work comes from Thermo Fisher
- NHS Blood and Transplant
- South West
- Direct
- 22 May 2026 to 31 March 2033
NHS Blood and Transplant buys a producer cell line for GMP viral vector packaging from Thermo Fisher Scientific.
The cell line is used on a manufacturing process for recombinant adeno-associated viral vectors (rAAV) at the Clinical Biotechnology Centre (CBC). The CBC recently validated the process to GMP standard after more than four years of work. It helps UK academic clients take gene therapy programmes into human clinical trials.
The process is highly sensitive to changes in its starting materials, and any change could mean months of costly rework. NHSBT awarded the £180,000 contract directly in April 2026, and it runs to March 2033.
Contract ends March 2033
- What
- Laboratory consumables, reagents and chemicals
- Supplier
- Thermo Fisher Scientific
- Value
- £180,000
- How it was bought
- Direct
- Dates and next
- May 2026 to Mar 2033